File(s) not publicly available
Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting
journal contribution
posted on 2023-05-21, 23:28 authored by Currie, CJ, McEwan, P, Poole, C, Valentine, WJ, Andrew PalmerAndrew Palmer, Lammert, M, Nicklasson, L, Foos, V, Roze, SNo description available
History
Publication title
Current Medical Research and OpinionVolume
22Issue
5Pagination
967-969ISSN
0300-7995Department/School
Menzies Institute for Medical ResearchPublisher
LibrapharmPlace of publication
C/O Dr. Peter L Clarke, 26-32 Venture West, New Greenham Park, Newbury, England, Berkshire, Rg19 6HxRepository Status
- Restricted